Clinical trial
Clinical Evaluation of the Efficacy and Tolerability of AnteAGE Biosomes and Facial Radiofrequency Microneedling
NCT07849556 is registered in ClinicalTrials.gov with Cellese Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Evaluation of the Efficacy and Tolerability of AnteAGE Biosomes and Facial Radiofrequency Microneedling
- Lead sponsor
- Cellese Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 3, 2024
- Completion date
- June 18, 2025
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
facial rhytides, skin aging, skin tone